Mediation of Amphetamine-Induced Long-Term Depression of Synaptic Transmission by CB1 Cannabinoid Receptors in the Rat Amygdala

Journal of Neuroscience

Volumn 23, Issue 32, 2003, Pages 10311-10320

  Huang, Ya Chun ^a   Wang, Su Jane ^b   Chiou, Lih Chu ^c   Gean, Po Wu ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Addiction; Amphetamine; Amygdala; Endocannabinoid; LTD; Synaptic plasticity

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR ANTAGONIST; DOPAMINE RECEPTOR BLOCKING AGENT; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PSYCHOSTIMULANT AGENT; SEROTONIN 1A ANTAGONIST; UNCLASSIFIED DRUG;

ADDICTION; AMYGDALOID NUCLEUS; ANIMAL MODEL; ARTICLE; BEHAVIOR; CALCIUM CELL LEVEL; CONDITIONING; CONTROLLED STUDY; DEPRESSION; MALE; MEDICAL RECORD; MEMORY; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

EID: 0344824650     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-32-10311.2003     Document Type: Article

References (43)

1. Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31-43.
2. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277:1094-1097.
3. Ben-Ari Y, Kelly JS (1976) Dopamine evoked inhibition of single cells of the feline putamen and basolateral amygdala. J Physiol (Lond) 256:1-21.
4. Bjijou Y, De Deurwaerdere P, Spampinato U, Stinus L, Cador M (2002) Amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex. Neuroscience 109:499-516.
5. Carson G, Wang Y, Alger BE (2002) Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 5:723-724.
6. Civelli O, Bunzow JR, Grandy DK (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 32:281-307.
7. Clausing P, Gough B, Holson RR, Slikker Jr W, Bowyer JF (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther 274:614-621.
8. Davis M, Rainnie D, Cassell M (1994) Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 17:208-214.
9. De Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, Vanderschuren LJ (1998) Drug-induced reinstatement of heroin- and cocaine-seeking behavior following long-term extinction is associated with expression of behavioral sensitization. Eur J Neurosci 10:3565-3571.
10. Fallon JH, Koziell DA, Moore RY (1978) Catecholamine innervation of the basal forebrain. I. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 180:509-532.
11. Garattini S, Jori A, Samanin R (1976) Interactions of various drugs with amphetamine. Ann NY Acad Sci 281:409-425.
12. Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5:446-451.
13. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358-363.
14. Harmer CJ, Phillips GD (1999) Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus: facilitation by prior repeated d-amphetamine. Neuroscience 90:119-130.
15. A synaptic transmission in the hippocampus. J Neurosci 20:2470-2479.
16. Hsu EH, Schroeder JP, Packard MG (2002) The amygdala mediates memory consolidation for an amphetamine conditioned place preference. Behav Brain Res 129:93-100.
17. Huang CC, Hsu KS, Gean PW (1996) Isoproterenol potentiates synaptic transmission primarily by enhancing presynaptic calcium influx via P-and/or Q-type calcium channels in the rat amygdala. J Neurosci 16:1026-1033.
18. Jones S, Kauer JA (1999) Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. J Neurosci 19:9780-9787.
19. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
20. Kreitzer AC, Regehr WG (2001a) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717-727.
21. Kreitzer AC, Regehr WG (2001b) Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21:RC174(1-5).
22. LeDoux JE (2000) Emotion circuits in the brain. Annu Rev Neurosci 23:155-184.
23. Llinas R, Steinberg IZ, Walton K (1981) Presynaptic calcium currents in squid giant synapse. Biophys J 33:289-322.
24. Lokiec F, Rapin JR, Jacquot C, Cohen Y (1978) A comparison of the kinetics of d- and l-amphetamine in the brain of isolated and aggregated rats. Psychopharmacology 58:73-77.
25. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M (2001) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31:463-475.
26. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid systen controls extinction of aversive memories. Nature 418:530-534.
27. McDonald AJ, Mascagni F (2002) Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a sub-population of cholecystokinin-containing interneurons. Neuroscience 107:641-652.
28. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-738.
29. Ong WY, Mackie K (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 92:1177-1191.
30. Piazza PV, Deminiere JM, Le Moal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513.
31. Piomelli D, Beltramo M, Glasnapp S, Lin SY, Goutopoulos A, Xie XQ, Makriyannis A (1999) Structure determinants for recognition and translocation by the anadamide transporter. Proc Natl Aca Sci USA 96:5802-5807.
32. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
33. Rosenkranz JA, Grace AA (1999) Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci 19:11027-11039.
34. Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 32:639-677.
35. Spector S, Sjoerdsma A, Udenfriend S (1965) Blockade of endogenous norepinephrine synthesis by α-methyl-p-tyrosine, an inhibitor of tyrosine hydroxylase. J Pharmacol Exp Ther 147:86-95.
36. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
37. Ungerstedt U (1971) Stereotaxic mapping of monoamine pathways in the rat brain. Acta Physiol Scand 82 [Suppl 367]:1-48.
38. Wang SJ, Sihra TS, Gean PW (2001) Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. NeuroReport 12:2255-2258.
39. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410:588-592.
40. Wise RA (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22.
41. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
42. Wolf ME (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
43. Zucker RS (1989) Short-term synaptic plasticity. Annu Rev Neurosci 12:13-31.